NCT04260594View on ClinicalTrials.gov

Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus

PHASE4CompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

February 8, 2020

Primary Completion Date

March 12, 2020

Study Completion Date

December 30, 2020

Conditions
2019-nCoV
Interventions
DRUG

Arbidol

Arbidol tablets: take 2 tablets/time, 3 times/day for 14-20 days

OTHER

basic treatment

basic treatment

Trial Locations (1)

200025

Ruijin Hospital, Medical School of Shanghai Jiaotong University, Shanghai

All Listed Sponsors
lead

Jieming QU

OTHER

NCT04260594 - Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus | Biotech Hunter | Biotech Hunter